Loading, Please Wait...
Life Science Teams Are Invited to Join 3,300 Colleagues for Three Days of Presentations and Collaboration; Event Coverage Includes the Latest Advancements for Clinical, Informatics, Diagnostics and Cancer Research
NEEDHAM, MA --(Marketwired - February 12, 2016) - Cambridge Healthtech Institute, a leading provider of life science conferences, is pleased to offer pharma, biotech, healthcare and technology teams complimentary access to the 23rd International Molecular Medicine Tri-Conference keynote presentations and exhibit hall, March 7-9, 2016 at San Francisco's Moscone North Convention Center. The 2016 program features keynote presentations by two of the industry's most-respected innovators, Jorge Soto, Co-Founder and CTO of Miroculus; and Stephen Kingsmore, President and CEO of Rady Pediatric Genomics & Systems Medicine Institute.
"Molecular Medicine Tri-Conference has been and will continue to be a platform in recognizing the potential for new technologies and research in molecular medicine, diagnostics, drug discovery, and drug development that have a pivotal role in mitigating disease, improving access to healthcare, and identifying transformative treatments," states Cindy Crowninshield, Executive Conference Director at Cambridge Healthtech Institute. "The 2016 plenary keynote presenters will inspire you to continue efforts in developing novel medicines, diagnostics, therapeutics, and approaches to gain a greater understanding of the underpinnings of cancer and advance personalized medicine."
The complimentary keynote and exhibit hall pass provides visitors with access to 200 exhibiting companies, more than 150 scientific research posters, a new products showcase, vendor theater presentations, the annual networking reception and the highly anticipated keynote presentations. Attracting more than 3,300 scientific professionals annually, the event equips teams with the latest developments in diagnostic, genomic, informatics and cancer research.
Visitors also gain admission to their choice of 20 interactive breakout sessions, providing the opportunity to discuss pressing questions across specialized topics, such as responding to FDA updates on IVDs, laboratory data analysis, NGS assay validation and rapid infection disease detection.
Complimentary hall passes are available until February 26. A full schedule and online registration can be found at http://www.triconference.com/hallpass.
About Molecular Medicine Tri-Conference (
Cambridge Healthtech Institute's flagship event, with over a twenty year history, Molecular Medicine Tri-Conference is the premier event on molecular medicine & diagnostics. Attracting over 3,300 drug discovery and development professionals from over 40 countries, the Tri-Conference has grown into a diverse event, focusing on Molecular Medicine, specifically on Discovery, Genomics, Diagnostics and Information Technology.
About Cambridge Healthtech Institute (
Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute, is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, CROs, academia, and niche service providers. CHI is renowned for its vast conference portfolio held worldwide including PepTalk, Molecular Medicine Tri-Conference, SCOPE Summit, Bio-IT World Conference & Expo, PEGS Summit, Drug Discovery Chemistry, Biomarker World Congress, World Pharmaceutical Congress, Next Generation Dx Summit and Discovery on Target. CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Knowledge Foundation Bio-IT World Clinical Informatics News and Diagnostics World.
Corporate Marketing Director
Cambridge Healthtech Institute